Ballentine Partners LLC Buys 396 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ballentine Partners LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,847 shares of the medical equipment provider’s stock after purchasing an additional 396 shares during the quarter. Ballentine Partners LLC’s holdings in Intuitive Surgical were worth $1,890,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Creekmur Asset Management LLC boosted its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $26,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the period. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical during the first quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $511.27 on Friday. The stock has a market capitalization of $182.10 billion, a PE ratio of 82.20, a P/E/G ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34. The business’s fifty day moving average price is $487.34 and its 200-day moving average price is $441.45.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 52,192 shares of company stock valued at $25,398,571 over the last three months. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ISRG. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. Truist Financial lifted their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Raymond James lifted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Finally, BTIG Research set a $535.00 price target on Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.